X0609 4 2026-09-15 0001583107 Theravance Biopharma, Inc. TBPH 0001898490 Farnum Rhonda false C/O THERAVANCE BIOPHARMA US, LLC 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 false true false false SVP, COMM & MEDICAL AFFAIRS 1 Ordinary Shares 2026-09-15 4 S 0 3329 17.0341 D 223461 D Ordinary Shares 2026-09-15 4 S 0 3328 17.0343 D 220133 D Ordinary Shares 2026-09-15 4 S 0 6657 17.0342 D 213476 D This transaction was executed in multiple trades at prices from $17.02 to $17.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. These transactions were executed in accordance with the reporting person's 10b5-1 plan dated 09/03/2025. /s/ Brett A. Grimaud, Attorney-in-Fact 2026-09-17